Status:
UNKNOWN
Study of the Diagnostic Value of Hybrid PET/MR and PET/CT in Neuroendocrine Diseases and Tumor Induced Osteomalacia
Lead Sponsor:
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Conditions:
PET / CT
PET / MR
Eligibility:
All Genders
20-80 years
Brief Summary
Neuroendocrine tumors (NETs) are rare neoplasms arising from the diffuse endocrine system and spreading throughout the different organs and tissues of the body. Tumor-induced osteomalacia (TIO) , is a...
Detailed Description
Neuroendocrine tumors (NETs) are rare neoplasms arising from the diffuse endocrine system and spreading throughout the different organs and tissues of the body. Tumor-induced osteomalacia (TIO), is a ...
Eligibility Criteria
Inclusion
- Patients with suspected or confirmed NETs or patients with suspected TIO
Exclusion
- Acute systemic diseases and electrolyte disorders.
- Pregnant or lactating women.
- Participated in other clinical trials within 4 weeks before the start of the study.
Key Trial Info
Start Date :
May 5 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2023
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT04045834
Start Date
May 5 2019
End Date
December 31 2023
Last Update
February 14 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
China, Hubei Province
Wuhan, Hubei, China, 430022